Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy

NCT01694966 is registered in ClinicalTrials.gov with Cosmo Technologies Ltd as lead sponsor.

NCT NCT01694966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01694966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Lead sponsor
Cosmo Technologies Ltd
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2013
Completion date
October 31, 2016
Enrollment
1,249 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer